Table 2.
Subject | levodopa/carbidopa | amantadine | isradapine | pramipexole | trihexyphenidyl | rasagiline |
---|---|---|---|---|---|---|
| ||||||
A | 75/300 | 200 | 1.5 | |||
B | 300 | 3 | ||||
C | 3 | 4 | 2 | |||
D | 75/300 | |||||
E | 10 |
Subject | levodopa/carbidopa | amantadine | isradapine | pramipexole | trihexyphenidyl | rasagiline |
---|---|---|---|---|---|---|
| ||||||
A | 75/300 | 200 | 1.5 | |||
B | 300 | 3 | ||||
C | 3 | 4 | 2 | |||
D | 75/300 | |||||
E | 10 |